The Antimicrobial peptide Lab
The Antimicrobial peptide Lab
Embedded Files
Antimicrobial resistance (AMR) poses a growing threat to global health, reducing the effectiveness of conventional antibiotics and challenging our ability to treat infectious diseases. At The Antimicrobial Peptide Lab a.k.a CB Lab, we are committed to advancing the understanding and application of antimicrobial peptides (AMPs), also known as host-defense peptides, as potential solutions to this crisis.
Our research explores how these naturally occurring molecules interact with bacterial cells, the mechanisms through which they inhibit microbial growth, and how they can be optimized for enhanced therapeutic potential. By integrating microbiology, molecular biology, biophysics, and computational approaches, we investigate peptide–pathogen interactions at the molecular level and develop strategies to combat multidrug-resistant bacteria.
Through interdisciplinary research and scientific innovation, our goal is to contribute to the global fight against AMR while fostering a collaborative environment for learning, discovery, and translational impact.
Page updated
Google Sites
Report abuse